Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.56 |
| ▸ | MCL1 | Q07820 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propionic Acid SCHEMBL10538956 | 0.97 | FFAR3 (0.53) | FFAR3MCL1ALDH1A1HDAC3HDAC1 | |
| Propionic Acid SCHEMBL2141793 | 0.97 | FFAR3 (0.53) | FFAR3MCL1ALDH1A1HDAC3HDAC1 | |
| Propionic Acid SCHEMBL28451920 | 0.97 | FFAR3 (0.53) | FFAR3MCL1ALDH1A1HDAC3HDAC1 | |
| Alcohol SCHEMBL4450662 | 0.89 | — | — | |
| Methyl Alcohol SCHEMBL27928369 | 0.88 | — | — | |
| Ethane SCHEMBL621831 | 0.88 | — | — | |
| SCHEMBL30536998 | 0.88 | — | — | |
| SCHEMBL30022145 | 0.88 | — | — | |
| SCHEMBL16130 | 0.88 | — | — | |
| SCHEMBL27567423 | 0.88 | MCL1 (0.53) | FFAR3MCL1ALDH1A1KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11898250-B2 | Formulation for the etching of polymer materials prior to coating of the materials | AVANZARE INNOVACIÓN TECNOLÓGICA, S.L. (ES) | 2024-02-13 | — | — | US | claimed |
| EP-3689477-A1 | FORMULATION FOR MORDANTING POLYMERIC MATERIALS PRIOR TO COATING SAME | Avanzare Innovacion Tencologica S.L. (ES) | 2020-08-05 | — | — | EP | claimed |
| CN-111201091-A | Formulations for etching polymeric materials prior to coating thereof | 阿万扎雷创新科技有限公司 | 2020-05-26 | — | — | CN | claimed |
| US-20200080203-A1 | FORMULATION FOR THE ETCHING OF POLYMER MATERIALS PRIOR TO COATING OF THE MATERIALS | AVANZARE INNOVACION TECNOLOGICA S L (ES) | 2020-03-12 | — | — | US | claimed |
| US-10501852-B2 | Formulation for the etching of polymer materials prior to coating of the materials | AVANZARE INNOVACIÓN TECNOLÓGICA, S,L. (ES) | 2019-12-10 | — | — | US | claimed |
| US-20190136381-A1 | FORMULATION FOR THE ETCHING OF POLYMER MATERIALS PRIOR TO COATING OF THE MATERIALS | AVANZARE INNOVACIÓN TECNOLÓGICA, S,L. (ES) | 2019-05-09 | — | — | US | claimed |
| US-11898250-B2 | Formulation for the etching of polymer materials prior to coating of the materials | AVANZARE INNOVACIÓN TECNOLÓGICA, S.L. (ES) | 2024-02-13 | — | — | US | disclosed |
| US-11761091-B2 | Surface activated polymers | SRG GLOBAL LIRIA, S.L. (ES) | 2023-09-19 | — | — | US | disclosed |
| EP-3848483-A2 | SURFACE ACTIVATED POLYMERS | SRG Global Liria, S.L. (ES) | 2021-07-14 | — | — | EP | disclosed |
| EP-3565915-B1 | SURFACE ACTIVATED POLYMERS | SRG GLOBAL LIRIA S L (ES) | 2021-01-20 | — | — | EP | disclosed |
| US-20200255947-A1 | SURFACE ACTIVATED POLYMERS | SRG GLOBAL LIRIA S.L. (ES) | 2020-08-13 | — | — | US | disclosed |
| CN-111511962-A | Surface-activated polymers | SRG利里亚全球有限公司 | 2020-08-07 | — | — | CN | disclosed |
| EP-3689477-A1 | FORMULATION FOR MORDANTING POLYMERIC MATERIALS PRIOR TO COATING SAME | Avanzare Innovacion Tencologica S.L. (ES) | 2020-08-05 | — | — | EP | disclosed |
| EP-2740500-A2 | Composition for use in the prophylaxis of post-surgical adhesions | AESCULAP AG (DE) | 2014-06-11 | — | — | EP | disclosed |
| EP-2261264-B1 | METHOD OF MANUFACTURING PARTICULATE WATER ABSORBENT WITH WATER-ABSORBENT RESIN AS MAIN INGREDIENT | NIPPON CATALYTIC CHEM IND (JP) | 2013-10-09 | — | — | EP | disclosed |
| US-20120064535-A1 | METHOD OF PREPARING SAMPLES CONTAINING NUCLEIC ACIDS | OLYMPUS CORPORATION (JP) | 2012-03-15 | — | — | US | disclosed |
| US-20110039961-A1 | Method for producing particulate water absorbing agent containing water absorbent resin as main component | NIPPON SHOKUBAI CO., LTD. (JP) | 2011-02-17 | — | — | US | disclosed |
| EP-2261264-A1 | METHOD OF MANUFACTURING PARTICULATE WATER ABSORBENT WITH WATER-ABSORBENT RESIN AS MAIN INGREDIENT | Nippon Shokubai Co., Ltd. (JP) | 2010-12-15 | — | — | EP | disclosed |
| US-7704307-B2 | containing water soluble palladium compound, at least one of ammonia, an amine compound, an aminocarboxylic acid compound, carboxylic acid, and bismuth; plating liquid has good stability and provides a film with excellent corrosion resistance, solder bondability, and wire bondability | NIPPON MINING & METALS CO., LTD. (JP) | 2010-04-27 | — | — | US | disclosed |
| US-20090081369-A1 | containing water soluble palladium compound, at least one of ammonia, an amine compound, an aminocarboxylic acid compound, carboxylic acid, and bismuth; plating liquid has good stability and provides a film with excellent corrosion resistance, solder bondability, and wire bondability | JX NIPPON MINING & METALS CORPORATION (JP) | 2009-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120064535-A1 | METHOD OF PREPARING SAMPLES CONTAINING NUCLEIC ACIDS | ADAR, POLRMT, NOP2 | FFAR3 3908/4885MCL1 3647/4885ALDH1A1 2312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.